You just read:

Relmada Therapeutics Announces Notice of Acceptance of Key Patent in Europe Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms

News provided by

Relmada Therapeutics, Inc.

Jan 09, 2018, 08:00 ET